Effects are seen primarily in people with carnitine deficiency (vegetarians, older adults, people with kidney disease) and in specific training protocols
UTMD-mediated IGF-1 transfection enhanced inflammatory cell infiltration, reduced scar tissue formation, and improved maximum load, stiffness, and ultimate stress at weeks 2 and 8 (Tang et al., 2015)
While the RNI for maintenance is only 1.5 g daily, therapeutic oral doses typically range from: 50-150 g daily for mild deficiency prevention in at-risk groups 1,000-2,000 g daily for treating confirmed deficiency without malabsorption Some formulations contain up to 5,000 g, though there is no proven additional benefit over 1,000-2,000 g for most patients The reason for this dosage discrepancy lies in absorption efficiency
Serious side effects are rare, but consult a healthcare professional if you experience unusual reactions
Therapeutic Research Protocol Dose: 0.3 0.5 mg (= 610 clicks) Duration: 12 weeks Frequency: 2 3 daily, spaced 4 6 hours apart Cycle Interval: 4 6 weeks off before repeating Goal / Description: Higher-amplitude GH and IGF-1 elevation in regenerative and metabolic models
TB-500 is likewise not FDA-approved for any indication
